Esophageal Cancer News and Research

RSS

Esophageal Cancer is cancer that forms in tissues lining the esophagus (the muscular tube through which food passes from the throat to the stomach). Two types of esophageal cancer are squamous cell carcinoma (cancer that begins in flat cells lining the esophagus) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids).

Non-invasive, novel urinary miRNA biomarker panel for colorectal cancer diagnosis

Researchers set out to develop and validate urine biomarkers for diagnosing gastric cancer and colorectal cancer.

19 Jan 2022

Researchers discover how oral bacteria increase vulnerability to infection

Researchers from the University of Louisville School of Dentistry and their colleagues have discovered details of how proteins produced by oral epithelial cells protect humans against viruses entering the body through the mouth.

5 Jan 2022

Indication of minor added benefit of nivolumab for adjuvant treatment of esophageal cancer

In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care investigated whether nivolumab has an added benefit over watchful waiting in the adjuvant treatment of adults with carcinoma of the esophagus or the gastroesophageal junction and pathological residual disease after prior neoadjuvant chemoradiotherapy (CRT).

10 Dec 2021

Researchers develop a digital tool to better monitor Barrett's esophagus

A team including researchers from the Department of Energy's Oak Ridge National Laboratory has developed a digital tool to better monitor a condition known as Barrett's esophagus, which affects more than 3 million people in the United States.

12 Nov 2021

Chromosome aberrations linked to acute toxicities in esophageal cancer patients

Japanese researchers identified chromosome aberrations as a new biomarker in predicting an esophageal cancer patient's risk of experiencing severe chemoradiotherapy side effects.

28 Oct 2021

High levels of cancer-fighting immune cells could indicate a better chance of survival

Cancerous tumors are made up of many more components than just malignant cells from the tissue of origin. Immune cells can be recruited to the tumor site and form what is known as the tumor microenvironment.

18 Oct 2021

Doubling excise duties could prevent alcohol-attributable cancers

In a recent modeling study, scientists at Technische Universität Dresden have examined the impact of increasing taxes on alcoholic beverages on alcohol-attributable cancers in the World Health Organization (WHO) European Region.

22 Sep 2021

Study highlights the significance of screening for pre-cancerous Barrett’s esophagus

Abnormal cells that go on develop into oesophageal cancer – cancer that affects the tube connecting the mouth and stomach – start life as cells of the stomach, according to scientists at the University of Cambridge.

13 Aug 2021

Family history modifies the link between blood lipids and esophageal cancer risk

Several studies have associated blood lipids with different types of cancer like that of the food pipe or “esophagus,” but much remains to be understood, to apply this knowledge clinically.

24 Jun 2021

CU Cancer Center researcher investigates new treatment sequence for esophageal cancer

Looking for better ways to treat patients with esophageal cancer, University of Colorado Cancer Center member Martin McCarter, MD, is investigating whether a new treatment sequence will result in better outcomes.

22 Jun 2021

Aiding her dying husband, a geriatrician learns the emotional and physical toll of caregiving

The loss of a husband. The death of a sister. Taking in an elderly mother with dementia.

18 May 2021

Esophageal cancers turn on ancient viral DNA hidden in our genome

Scientists have discovered that many esophageal cancers turn on ancient viral DNA that was embedded in our genome hundreds of millions of years ago.

10 May 2021

New approach can help identify patients at risk for esophageal cancer

A combination of esophageal brushing and extensive genetic sequencing of the sample collected can detect chromosome alterations in people with Barrett's Esophagus, identifying patients at risk for progressing to esophageal cancer, according to a new study by researchers at the Johns Hopkins Kimmel Cancer Center and Case Western Reserve University.

29 Mar 2021

New technique may result in earlier and easier identification of patients with Barrett's esophagus

A new technique for sampling and testing cells from Barrett's esophagus (BE) patients could result in earlier and easier identification of patients whose disease has progressed toward cancer or whose disease is at high risk of progressing toward cancer, according to a collaborative study by investigators at Case Western Reserve University and Johns Hopkins Kimmel Cancer Center (JHKCC).

23 Mar 2021

Esophageal Cancer News and Research

Further Reading

Non-invasive, novel urinary miRNA biomarker panel for colorectal cancer diagnosis

Researchers discover how oral bacteria increase vulnerability to infection

Indication of minor added benefit of nivolumab for adjuvant treatment of esophageal cancer

Researchers develop a digital tool to better monitor Barrett's esophagus

Chromosome aberrations linked to acute toxicities in esophageal cancer patients

High levels of cancer-fighting immune cells could indicate a better chance of survival

Doubling excise duties could prevent alcohol-attributable cancers

Study highlights the significance of screening for pre-cancerous Barrett’s esophagus

Family history modifies the link between blood lipids and esophageal cancer risk

CU Cancer Center researcher investigates new treatment sequence for esophageal cancer

Aiding her dying husband, a geriatrician learns the emotional and physical toll of caregiving

Esophageal cancers turn on ancient viral DNA hidden in our genome

New approach can help identify patients at risk for esophageal cancer

New technique may result in earlier and easier identification of patients with Barrett's esophagus

Newly identified drugs can help treat oral and esophageal carcinomas

Older patients often do not receive optimal therapy for esophageal cancers due to perceived risks

Novel 3D-printed esophageal stents could revolutionize the delivery of cancer treatment

Dramatic changes seen in delivery of radiotherapy treatments during coronavirus pandemic

Certain oral pathogens are more prevalent in esophageal cancer patients

Absence of anti-tumor protein may cause resistance to EGFR-targeting therapies

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News